• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE FLEX EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE FLEX EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PED-325-12
Device Problems Detachment of Device or Device Component (2907); Activation Failure (3270)
Patient Problem Thrombosis (2100)
Event Date 08/16/2016
Event Type  Injury  
Manufacturer Narrative
The pipeline flex pushwire was returned for evaluation without the braid as it was implanted in the patient.It was confirmed that the pipeline flex pushwire was detached at the hypotube proximal to the wire weld.The distal hypotube appeared to be stretched with the ptfe shrink tubing still intact.The pushwire was observed to be bent approximately 32.5cm from the proximal end.The pipeline flex is still undergoing investigation.A follow-up mdr will be submitted when investigation is complete.
 
Event Description
Medtronic received report of pipeline flex pushwire separation as well as clot formation during a procedure.The patient was undergoing treatment for an unruptured, saccular aneurysm at the left internal carotid artery (ica) terminus.The an eurysm max.Diameter was 14mm and neck diameter was 5mm.Landing zone artery size was 2.80mm distal and 3.23mm proximal.The vessel was minimally tortuous.The devices were prepared as indicated in the ifu.The pipeline flex was deployed.The physician attempted to resheath the device in order to reposition it at which time the pushwire separated at the proximal portion of the resheathing pad.There was reportedly no friction or difficulty when separation occurred.The physician attempted to pull and retrieve the entire system (including the partially deployed device) into the intermediate catheter, but the device deployed into the ica/m1 middle cerebral artery (mca) segment.When deployed, the braid was only partially covering (90%) the aneurysm neck and the proximal section was not fully open.An unsuccessful attempt was made to snare the braid as well as the detached wire (which was inside the braid).Afterward, the snare was used to bump the proximal end of the braid, which fully opened.The broken wire was able to be snared and removed.A new catheter was used to access the neck of the aneurysm and implant coils.Angiography demonstrated possible clot formation along the device.A bolus of reopro was administered followed by iv drip.
 
Manufacturer Narrative
Additional manufacturer narrative - device evaluation, additional information in regards to the report of pipeline flex failure to open, the event could not be confirmed as the braid was not returned for evaluation; the cause for the braid failure to open could not be conclusively determined from the reported information.In regards to the report of pipeline flex pushwire detachment at the hypotube proximal to the wire weld, the event was confirmed based on gross analysis as well as scanning electron micrographic (sem) / energy dispersive x-ray spectroscopy (eds) analysis.The distal wire was possibly detached due to tensile failure.From the damage observed on the proximal wire (bending) and hypotube (stretching), it is likely that excessive force was applied by the user (pushing and pulling) subsequently causing the solder joint to separate.A review of the manufacturing process did not uncover any deficiencies in regards to the soldering process.Proper soldering technique and surface preparation are well defined and documented appropriately in the associated manufacturing procedures.In addition, the elemental analysis conducted through sem and eds indicate presence of soldering material, thereby indicating that the soldering was conducted.The lot history record of the reported lot number was reviewed and no discrepancies that might have caused the reported event were noted.All products are 100% inspected for damage and irregularities during manufacture.Per our instructions for use (ifu): "discontinue delivery of the device if high force or excessive friction is encountered.Identify the cause of the resistance and remove device and microcatheter simultaneously.Advancement of the ped against resistance may result in device damage or patient injury.Never advance or withdraw an intraluminal device against resistance until the cause of resistance is determined by fluoroscopy.If the cause cannot be determined, withdraw the catheter.Movement of the micro catheter against resistance may result in damage to the micro catheter, or the vessel.¿.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE FLEX EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key5943155
MDR Text Key54445940
Report Number2029214-2016-00801
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/20/2018
Device Model NumberPED-325-12
Device Lot NumberA150535
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/24/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/16/2016
Initial Date FDA Received09/12/2016
Supplement Dates Manufacturer ReceivedNot provided
10/06/2016
Supplement Dates FDA Received11/01/2016
09/25/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/21/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient Weight108
-
-